High flow oxygen therapy (HFO) in patients with acute respiratory failure: hemodynamics, gas exchange and respiratory mechanics measurements in lung alveoli

A. Naya Prieto (Madrid, Spain), C. López Chang (Madrid, Spain), M. Fernández Ormaechea (Madrid, Spain), L. De La Dueña Muñoz (Madrid, Spain), M. Carballosa De Miguel (Madrid, Spain), P. Zazu López (Madrid, Spain), J. Reyes Ussetti (Madrid, Spain), L. Jiménez Hiscock (Madrid, Spain), M. Rodríguez Nieto (Madrid, Spain), G. Peces Barba (Madrid, Spain), S. Heili Frades (Madrid, Spain)

Source: Respiratory Failure and Mechanical Ventilation Conference 2022 - Opening session: Essentials of respiratory physiology - Assessment of respiratory muscle function - Pulmonary infections in mechanically ventilated patients - Telemonitoring of patients with chronic respiratory failure - Diagnostics and interventions - Acute respiratory failure: COVID-19 - Interstitial lung disease and pulmonary hypertension - Early rehabilitation - Acute respiratory failure: Invasive mechanical ventilation - HFNO and NIV for acute hypoxemic failure - Longterm NIV miscellaneous - Controversies in acute respiratory failure - The role of respiratory muscle dysfunction in weaning failure - Transitions in chronic NIV - New insights in weaning from invasive ventilation - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Difficult weaning from mechanical ventilation - Chronic ventilatory support in different diseases: Is one way fitting all? - Strategies to optimise early mobilisation and rehabilitation in intensive care - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Acute respiratory failure: Hypercapnic and diagnosis - Weaning from mechanical ventilation - Mechanical ventilation in the acute setting - Health-related quality of life in mechanical ventilation - Long-term noninvasive ventilation: Diagnosis and outcome - Long-term noninvasive ventilation: Outcome - Acute respiratory failure: Physiology
Session: Acute respiratory failure: Physiology
Session type: Oral poster discussion
Number: 137

Congress or journal article abstractWebcastPDF journal article, handout or slidesE-poster

Abstract

Alveolar pressure generated by HFO has been inferred from nasopharyngeal pressure or EELV measurements using bioimpedance. We conducted a prospective observational study to verify in situ the alveolar pressure at different flows.

A high-precision pressure Millar® Mikro-Cath able to reach respiratory zone of human lung was endoscopically placed in 5 random  spontaneously breathing patients. They received first O2 through face mask 15 L/m, and then all randomly received HFO at 15, 30, 50 and 60 L/m for two minutes each. After each step cardiac rate, invasive blood pressure and arterial blood gases were collected. A surface electromyography sensor was placed to assess respiratory effort. We collected Positive End-Expiratory Pressure (PEEP), minimum Peak Inspiratory Pressure (PIP), difference between PEEP and PIP, respiratory rate (RR), Inspiratory time (Ti) and Expiratory time (Te)

Compared with face mask, at HFO 60L/m PEEP increased (4,46 cmH20 vs 8,24 p<,001). The presence of PEEP in subjects in face mask should be highlighted, this may be attributable to autoPEEP or expiratory effort. Te (1,80 sec vs 2,02 p 0,023) and PaO2 also increased. Ti (1,42 vs 1,14 p<,001) and RR (20,88 vs 20 p 0,017) decreased. As a potential P-SILI, pressure oscillations (PEEP-PIP) increased at HFO 60 L/m (9,09 vs 13,66 p<,001). No differences were found in haemodynamics or arterial blood gases apart from PaO2.

In conclusion, HFO 60 L/m improves PEEP and PaO2 without affecting haemodynamics or gas exchange. Caution may be paid with extreme flows of HFO, where P-SILI and WOB can be worsened, especially in obstructive and established lung damage subjects.

 



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Naya Prieto (Madrid, Spain), C. López Chang (Madrid, Spain), M. Fernández Ormaechea (Madrid, Spain), L. De La Dueña Muñoz (Madrid, Spain), M. Carballosa De Miguel (Madrid, Spain), P. Zazu López (Madrid, Spain), J. Reyes Ussetti (Madrid, Spain), L. Jiménez Hiscock (Madrid, Spain), M. Rodríguez Nieto (Madrid, Spain), G. Peces Barba (Madrid, Spain), S. Heili Frades (Madrid, Spain). High flow oxygen therapy (HFO) in patients with acute respiratory failure: hemodynamics, gas exchange and respiratory mechanics measurements in lung alveoli. Respiratory Failure and Mechanical Ventilation Conference 2022 - Opening session: Essentials of respiratory physiology - Assessment of respiratory muscle function - Pulmonary infections in mechanically ventilated patients - Telemonitoring of patients with chronic respiratory failure - Diagnostics and interventions - Acute respiratory failure: COVID-19 - Interstitial lung disease and pulmonary hypertension - Early rehabilitation - Acute respiratory failure: Invasive mechanical ventilation - HFNO and NIV for acute hypoxemic failure - Longterm NIV miscellaneous - Controversies in acute respiratory failure - The role of respiratory muscle dysfunction in weaning failure - Transitions in chronic NIV - New insights in weaning from invasive ventilation - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Difficult weaning from mechanical ventilation - Chronic ventilatory support in different diseases: Is one way fitting all? - Strategies to optimise early mobilisation and rehabilitation in intensive care - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Acute respiratory failure: Hypercapnic and diagnosis - Weaning from mechanical ventilation - Mechanical ventilation in the acute setting - Health-related quality of life in mechanical ventilation - Long-term noninvasive ventilation: Diagnosis and outcome - Long-term noninvasive ventilation: Outcome - Acute respiratory failure: Physiology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.